SEC Form D · filed June 22, 2017
Rubius Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Joanne Protano · Cambridge, MAExecTorben S. Nissen · Cambridge, MAExec · DirectorRoger S. Pomerantz · Cambridge, MADirectorDavid S. Epstein · Cambridge, MADirectorRobert S. Langer · Cambridge, MADirectorMichael S. Rosenblatt · Cambridge, MADirectorNoubar B. Afeyan · Cambridge, MADirectorPeter B. Hutt · Watertown, MADirectorHarvey F. Lodish · Cambridge, MADirectorTim D. Walsh · RENO, NVExec · DirectorKurt G. Deutsch · New York, NYDirectorKathleen F. Briscoe · RENO, NVExecRichard Sapp · San Diego, CADirectorChristine M. Cvijic · Palo Alto, CADirectorMichael Beaudoin · Newport Beach, CADirectorStephen Socolof · San Diego, CADirectorPECO Property Group LLC · Park City, UTDirectorCrosby E. Howard · Palm Desert, CADirectorSteve E. Nelson · Palm Desert, CADirectorMark Ranalli · Cambridge, MADirectorPeter Sacco · Cambridge, MADirectorJoseph Patrina · West Simsbury, CTExec · DirectorAllan Bernheimer · Pound Ridge, NYExecPeter B. Hutt · Waltham, MADirectorHarvey F. Lodish · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗